We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024
25 Apr 2024 - 27 Apr 2024

AACC Middle East 2023 to Explore Latest Trends in Clinical Pathology and Laboratory Medicine

By LabMedica International staff writers
Posted on 29 Sep 2023
Print article
Image: AACC Middle East is a two-day conference that brings the latest in laboratory medicine to the Middle East region (Photo courtesy of ADLM)
Image: AACC Middle East is a two-day conference that brings the latest in laboratory medicine to the Middle East region (Photo courtesy of ADLM)

The AACC Middle East Conference and Exposition will be held by the Association for Diagnostics & Laboratory Medicine (ADLM - formerly AACC, Washington, DC, USA) in partnership with Life Dx (Abu Dhabi, UAE) on October 7-8, 2023, at the Grand Hyatt Hotel in Dubai, UAE. At AACC Middle East 2023, attendees will have the chance to engage with industry leaders, healthcare experts, and academics in the field of clinical pathology and laboratory medicine. The exhibit area will attract over 1,000 attendees and feature leading companies in the In Vitro Diagnostics (IVD) sector.

The two-day conference will focus on emerging topics particularly relevant to the Middle East region, while the exposition will showcase the most recent advancements in various aspects such as mobile health, molecular diagnostics, mass spectrometry, next-generation sequencing, point-of-care technologies, and automation. The conference agenda includes educational programs and a dynamic exposition, featuring the newest trends in clinical lab medicine, diagnostics, and best practices from experts. Topics to be discussed range from infectious diseases and big data analytics to prenatal emerging technologies, along with core laboratory practices like sample transportation, lab management, and quality assurance. Each session will feature knowledgeable speakers from AACC's scientific leadership. The event offers a unique opportunity for attendees to network with peers and experts, both from the United States and the Middle East, to exchange insights on the latest in laboratory medicine.

AACC Middle East is tailored for a diverse audience including physicians, lab supervisors, lab directors and their assistants, lab managers, medical technologists, pathologists, immunologists, fellows, residents, and those in training, among other healthcare professionals with an interest in laboratory medicine. Participants will have the chance to explore the latest research and technologies in the field. They can also gain insights into effective lab management strategies to streamline workflows, improve testing accuracy, and subsequently enhance treatment decisions and patient outcomes. Moreover, attendees will also learn how to adopt modern lab testing methods and technology, along with data-driven practices for preanalytical, analytical, and postanalytical phases of sample processing.

Related Links:
Life Dx 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article


Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: AI analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer (Photo courtesy of Adobe Stock)

Blood-Based Machine Learning Assay Noninvasively Detects Ovarian Cancer

Ovarian cancer is one of the most common causes of cancer deaths among women and has a five-year survival rate of around 50%. The disease is particularly lethal because it often doesn't cause symptoms... Read more


view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more


view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more


view channel
Image: ‘Virtual biopsy’ allows clinicians to analyze skin noninvasively (Photo courtesy of Stanford Medicine)

Virtual Skin Biopsy Determines Presence of Cancerous Cells

When dermatologists spot an unusual mark on a patient's skin, they face a choice: monitor it for some time or remove it for biopsy. Similarly, when removing breast tumors, surgeons must send excised tissues... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.